False-positive Human Papillomavirus DNA tests in cervical screening: it is all in a definition
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Based on data from randomised controlled trials (RCT) on primary cervical screening, it has been reported that the problem of more frequent false-positive tests in Human Papillomavirus (HPV) DNA screening compared to cytology could be overcome. However, these reports predominantly operated with a narrow definition of a (false-)positive test. The aim of this paper was to illustrate how the narrow definition affected the measured adverse effects of HPV DNA screening compared with cytology screening.
Originalsprog | Engelsk |
---|---|
Tidsskrift | European Journal of Cancer |
Vol/bind | 47 |
Udgave nummer | 2 |
Sider (fra-til) | 255-261 |
Antal sider | 7 |
ISSN | 0959-8049 |
DOI | |
Status | Udgivet - jan. 2011 |
ID: 38295609